Malignant tumor of breast (disorder)
Breast
Year Started: 2011
Prospectively patient-consented samples
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | > 6 months |
Clinical records | 3 - 6 months |
Cold ischemic time | Immediate |
Freezer temperature logs | Immediate |
Genomic datasets | > 6 months |
Imaging data | 3 - 6 months |
Pathology records | 3 - 6 months |
Quality indicators | Immediate |
Treatment records | 3 - 6 months |
Warm ischemic time | > 6 months |
Male
Adult (> 40 years)
1 - 10 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Serum | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Whole blood | -60°C to -85°C | N/A | Affected | 51 - 75% |
Female
Adult (> 40 years)
501 - 1000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Serum | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 51 - 75% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 75% -99% |
Whole blood | -60°C to -85°C | N/A | Affected | 51 - 75% |
Malignant tumor of colon (disorder)
Colorectal
Year Started: 2011
Colorectal
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | > 6 months |
Clinical records | 3 - 6 months |
Cold ischemic time | Immediate |
Followup records | 3 - 6 months |
Freezer temperature logs | Immediate |
Genomic datasets | > 6 months |
Imaging data | 3 - 6 months |
Pathology records | 3 - 6 months |
Quality indicators | Immediate |
Treatment records | 3 - 6 months |
Warm ischemic time | > 6 months |
Male
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Serum | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 75% -99% |
Whole blood | -60°C to -85°C | N/A | Affected | 51 - 75% |
Female
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Serum | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 51 - 75% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 75% -99% |
Whole blood | -60°C to -85°C | N/A | Affected | 51 - 75% |
Carcinoma in situ of prostate (disorder)
Prostate
Year Started: 2013
Prospectively patient-consented samples
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | > 6 months |
Clinical records | 3 - 6 months |
Cold ischemic time | Immediate |
Followup records | 3 - 6 months |
Freezer temperature logs | Immediate |
Genomic datasets | > 6 months |
Imaging data | 3 - 6 months |
Pathology records | 3 - 6 months |
Quality indicators | Immediate |
Treatment records | 3 - 6 months |
Warm ischemic time | > 6 months |
Male
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Serum | -60°C to -85°C | N/A | Affected | 51 - 75% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 51 - 75% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 51 - 75% |
Whole blood | -60°C to -85°C | N/A | Affected | 51 - 75% |
Malignant tumor of ovary (disorder)
Gynae (ovary)
Year Started: 2012
Prospectively consented patients with malignancy in ovary
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | > 6 months |
Clinical records | 3 - 6 months |
Cold ischemic time | Immediate |
Followup records | 3 - 6 months |
Freezer temperature logs | Immediate |
Genomic datasets | > 6 months |
Imaging data | 3 - 6 months |
Pathology records | 3 - 6 months |
Quality indicators | Immediate |
Treatment records | 3 - 6 months |
Warm ischemic time | > 6 months |
Female
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 75% -99% | |
Serum | -60°C to -85°C | N/A | Affected | 75% -99% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 75% -99% |
Whole blood | -60°C to -85°C | N/A | Affected | 75% -99% |
Malignant neoplasm of endometrium of corpus uteri (disorder)
Gynae (Endometrium)
Year Started: 2012
Endometrium
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | > 6 months |
Clinical records | 3 - 6 months |
Cold ischemic time | Immediate |
Followup records | > 6 months |
Freezer temperature logs | Immediate |
Genomic datasets | > 6 months |
Imaging data | 0 - 3 months |
Pathology records | 3 - 6 months |
Quality indicators | Immediate |
Treatment records | > 6 months |
Warm ischemic time | > 6 months |
Female
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 75% -99% | |
Serum | -60°C to -85°C | N/A | Affected | 75% -99% | |
Tissue specimen | Surgical procedure (procedure) | -60°C to -85°C | N/A | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Affected | 75% -99% |
Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Non-affected | 75% -99% |
Whole blood | -60°C to -85°C | N/A | Affected | 75% -99% |